Injectable healing protocol: Dose: 2-3mg daily (higher end of range) Frequency: Daily throughout healing period Duration: Until wound resolves plus 1-2 weeks Injection site: Systemic (not into wound) Topical healing protocol: Concentration: 2-4% in wound-appropriate vehicle Application: 2-3 times daily to wound margins (not directly into open wounds) Duration: Throughout healing process Note: Consult healthcare provider for significant wounds GHK-CU pairs exceptionally well with BPC-157 and TB-500 for wound healing
This faster-than-normal heart rate is known as tachycardia
Intramuscular (IM) : Common sites include the upper arm (deltoid muscle), thigh (vastus lateralis), or buttocks (gluteus medius)
Peptide therapies like AOD9604 or tesamorelin can play a complementary role in bodycomposition and metabolic wellness, but outside of tesamorelins HIV indication, their weightloss evidence base is smaller and they should be framed as adjunctive tools rather than replacements for wellstudied GLP1 treatments
[DOI] [PMC free article] [PubMed] [Google Scholar] 131.Huang D., Lan H., Liu F., Wang S., Chen X., Jin K., Mou X
Nat Rev Gastroenterol Hepatol
